McCafferty JP - Search Results

1

Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.

Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP. Keller MB, et al. Among authors: mccafferty jp. J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72. doi: 10.1097/00004583-200107000-00010. J Am Acad Child Adolesc Psychiatry. 2001. PMID: 11437014 Clinical Trial.

2

Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.

Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS, Robin DW, Gergel I, McCafferty J, Roose S. Nelson JC, et al. Am J Psychiatry. 1999 Jul;156(7):1024-8. doi: 10.1176/ajp.156.7.1024. Am J Psychiatry. 1999. PMID: 10401446 Clinical Trial.

3

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

Rickels K, Zaninelli R, McCafferty J, Bellew K, Iyengar M, Sheehan D. Rickels K, et al. Am J Psychiatry. 2003 Apr;160(4):749-56. doi: 10.1176/appi.ajp.160.4.749. Am J Psychiatry. 2003. PMID: 12668365 Clinical Trial.

4

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK. Pollack MH, et al. Among authors: mccafferty jp. J Clin Psychiatry. 2001 May;62(5):350-7. doi: 10.4088/jcp.v62n0508. J Clin Psychiatry. 2001. PMID: 11411817 Clinical Trial.

5

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I. Roose SP, et al. JAMA. 1998 Jan 28;279(4):287-91. doi: 10.1001/jama.279.4.287. JAMA. 1998. PMID: 9450712 Clinical Trial.

6

A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.

Carette S, Calin A, McCafferty JP, Wallin BA. Carette S, et al. Among authors: mccafferty jp. Arthritis Rheum. 1989 Feb;32(2):158-65. doi: 10.1002/anr.1780320208. Arthritis Rheum. 1989. PMID: 2645874 Clinical Trial.

7

Incidence and management of diarrhea during longterm auranofin therapy.

Wallin BA, McCafferty JP, Fox MJ, Cooper DR, Goldschmidt MS. Wallin BA, et al. Among authors: mccafferty jp. J Rheumatol. 1988 Dec;15(12):1755-8. J Rheumatol. 1988. PMID: 3265956

8

SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.

Hieble JP, Sulpizio AC, Sarau HM, Flaim KE, Blumberg AL, McCafferty JP, Zeid RL. Hieble JP, et al. Among authors: mccafferty jp. Fundam Clin Pharmacol. 1989;3(6):621-42. doi: 10.1111/j.1472-8206.1989.tb00464.x. Fundam Clin Pharmacol. 1989. PMID: 2575569

9

Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.

Roesler JM, McCafferty JP, DeMarinis RM, Matthews WD, Hieble JP. Roesler JM, et al. Among authors: mccafferty jp. J Pharmacol Exp Ther. 1986 Jan;236(1):1-7. J Pharmacol Exp Ther. 1986. PMID: 2867209

10

Cardiovascular activity of SK&F 64139 in the hypertensive rat.

Hieble JP, McCafferty JP, Roesler JM, Pendleton RG, Gessner G, Carey R, Sarau HM, Goldstein M. Hieble JP, et al. Among authors: mccafferty jp. J Cardiovasc Pharmacol. 1983 Sep-Oct;5(5):889-97. doi: 10.1097/00005344-198309000-00029. J Cardiovasc Pharmacol. 1983. PMID: 6195482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page